Table 1.
The clinicopathological variables in patients with HCC (n = 202)
| Variables | Values (n = 202) |
|---|---|
| Age (years), mean (SD) | 50.41 (11.95) |
| Albumin (g/L), mean (SD) | 41.39 (3.75) |
| WBC (109/L), mean (SD) | 5.63 (1.67) |
| Neutrophil (109/L), mean (SD) | 3.46 (1.35) |
| Lymphocyte (109/L), mean (SD) | 1.49 (0.54) |
| Monocyte (109/L), mean (SD) | 0.48 (0.2) |
| PLT (109/L), mean (SD) | 161.72 (69.06) |
| Total bilirubin (μmol/L), mean (SD) | 14.94 (12) |
| Direct bilirubin (μmol/L), mean (SD) | 5.94 (6.55) |
| ALT (U/L), mean (SD) | 43.28 (34.19) |
| AST (U/L), mean (SD) | 46.90 (32.98) |
| PT (s), mean (SD) | 13.2 (0.98) |
| APTT (s), mean (SD) | 33.11 (4.32) |
| Tumor diameter (cm), mean (SD) | 5.77 (3.38) |
| Creatinine (μmol/L), mean (SD) | 86.55 (16.5) |
| PNI | 48.83 (4.8) |
| SII | 433.23 (325.61) |
| Hospital stay (days), mean (SD) | 15.43 (4.33) |
| Gender | |
| Male | 168 |
| Female | 34 |
| HBV | |
| Absence | 33 |
| Presence | 169 |
| Tumor capsular | |
| Absence | 142 |
| Presence | 60 |
| AFP | |
| ≤ 20 ng/mL | 74 |
| > 20 ng/mL | 128 |
| Edmondson grade | |
| I–II | 152 |
| III–IV | 50 |
| Tumor number | |
| Single | 153 |
| Multiple | 49 |
| Satellite nodules | |
| Absence | 186 |
| Presence | 16 |
| Cirrhosis | |
| Absence | 52 |
| Presence | 152 |
| BCLC stage | |
| 0/A | 141 |
| B | 40 |
| C | 21 |
| TNM stage | |
| I/II | 167 |
| III | 35 |
WBC white blood cell, PLT platelet, ALT alanine transaminase, AST aspartate transaminase, PT prothrombin time, PNI prognostic nutritional index, SII systemic immune-inflammation index, AFP alpha-fetoprotein, BCLC Barcelona Clinic Liver Cancer, TNM tumor-node-metastasis